{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T08:07:23Z","timestamp":1745395643259},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T00:00:00Z","timestamp":1508716800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["surg case rep"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s40792-017-0380-5","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T18:06:09Z","timestamp":1508781969000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Stage IV gastric cancer successfully treated by multidisciplinary therapy including chemotherapy, immunotherapy, and surgery: a case report"],"prefix":"10.1186","volume":"3","author":[{"given":"Makoto","family":"Kawamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideya","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Koya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Konomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Mitsugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risa","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Motoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Morisaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,23]]},"reference":[{"key":"380_CR1","doi-asserted-by":"crossref","unstructured":"Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12:354\u201362.","DOI":"10.3748\/wjg.v12.i3.354"},{"key":"380_CR2","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1016\/S1470-2045(13)70436-4","volume":"14","author":"L Shen","year":"2013","unstructured":"Shen L, Shan YS, Hu HM, Price TJ, Sirohi B, Yeh KH, et al. Management of gastric cancer in Asia: resource-stratified guidelines. Lancet. 2013;14:e535\u201347.","journal-title":"Lancet"},{"key":"380_CR3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/jso.24096","volume":"11","author":"H Okabe","year":"2016","unstructured":"Okabe H, Hata H, Ueda S, Zaima M, Tokuka A, Yoshimura T, et al. A phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for stage III gastric cancer: KUGC03. J Surg Oncol. 2016;11:36\u201341.","journal-title":"J Surg Oncol"},{"key":"380_CR4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.biopha.2015.03.003","volume":"72","author":"WM Feng","year":"2015","unstructured":"Feng WM, Tang CW, Guo HH, Bao Y, Fei MY. Prolonged adjuvant capecitabine chemotherapy improved survival of stage IIIA gastric cancer after D2 gastrectomy. Biomed Pharmacother. 2015;72:140\u20133.","journal-title":"Biomed Pharmacother"},{"key":"380_CR5","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJM198704093161501","volume":"316","author":"SA Rosenberg","year":"1987","unstructured":"Rosenberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S, et al. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med. 1987;316:889\u201397.","journal-title":"N Engl J Med"},{"key":"380_CR6","first-page":"3771","volume":"25","author":"M Katano","year":"2005","unstructured":"Katano M, Morisaki T, Koga K, Nakamura M, Onishi H, Matsumoto K, et al. Combination therapy with tumor cell-pulsed dendritic cells and activated lymphocytes for patients with disseminated carcinomas. Anticancer Res. 2005;25:3771\u20136.","journal-title":"Anticancer Res"},{"key":"380_CR7","first-page":"831","volume":"29","author":"M Nakamura","year":"2009","unstructured":"Nakamura M, Wada J, Suzuki H, Tanaka M, Katano M, Morisaki T. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer. Anticancer Res. 2009;29:831\u20136.","journal-title":"Anticancer Res"},{"key":"380_CR8","first-page":"2401","volume":"28","author":"J Wada","year":"2008","unstructured":"Wada J, Yamasaki A, Nagai S, Yanai K, Fuchino K, Kameda C, et al. Regulatory T-cells are possible effect prediction markers of immunotherapy for cancer patients. Anticancer Res. 2008;28:2401\u20138.","journal-title":"Anticancer Res"},{"key":"380_CR9","first-page":"4529","volume":"34","author":"T Morisaki","year":"2014","unstructured":"Morisaki T, Hirano T, Koya N, Kiyota A, Tanaka H, Umebayashi M, et al. NKG2D-directed cytokine-activated killer lymphocyte therapy combined with gemcitabine for patients with chemoresistant metastatic solid tumors. Anticancer Res. 2014;34:4529\u201338.","journal-title":"Anticancer Res"},{"key":"380_CR10","first-page":"2385","volume":"32","author":"H Onishi","year":"2012","unstructured":"Onishi H, Koya N, Kiyota A, Tanaka H, Umebayashi M, Katano M, Morisaki T. A new method for rapid cytotoxic T-lymphocyte induction using a multiple cytokine cocktail. Anticancer Res. 2012;32:2385\u201390.","journal-title":"Anticancer Res"},{"key":"380_CR11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10120-015-0575-z","volume":"19","author":"K Yoshida","year":"2016","unstructured":"Yoshida K, Yamaguchi K, Okumura N, Tanahashi T, Kodera Y. Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification. Gastric Cancer. 2016;19:329\u201338.","journal-title":"Gastric Cancer"},{"key":"380_CR12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0169-5002(95)00478-J","volume":"13","author":"H Kimura","year":"1995","unstructured":"Kimura H, Yamaguchi Y. Adjuvant immunotherapy with interleukin 2 and lymphokine-activated killer cells after noncurative resection of primary lung cancer. Lung Cancer. 1995;13:31\u201344.","journal-title":"Lung Cancer"},{"key":"380_CR13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00262-014-1613-0","volume":"64","author":"H Kimura","year":"2015","unstructured":"Kimura H, Matsui Y, Ishikawa A, Nakajima T, Yoshino M, Sakairi Y. Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer. Cancer Immunol Immunother. 2015;64:51\u20139.","journal-title":"Cancer Immunol Immunother"},{"key":"380_CR14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00262-012-1311-8","volume":"62","author":"L Yang","year":"2013","unstructured":"Yang L, Ren B, Li H, Yu J, Cao S, Hao X, Ren X. Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small cell lung cancer patients. Cancer Immunol Immunother. 2013;62:65\u201373.","journal-title":"Cancer Immunol Immunother"},{"key":"380_CR15","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/stem.2039","volume":"33","author":"Q Pan","year":"2015","unstructured":"Pan Q, Li Q, Liu S, Ning N, Zhang X, Xu Y, Chang AE, Wicha MS. Concise review: targeting cancer stem cells using immunologic approaches. Stem Cells. 2015;33:2085\u201390.","journal-title":"Stem Cells"},{"key":"380_CR16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.drup.2012.03.003","volume":"15","author":"TJ Curiel","year":"2012","unstructured":"Curiel TJ. Immunotherapy: a useful strategy to help combat multidrug resistance. Drug Resistance Updates. 2012;15:106\u201313.","journal-title":"Drug Resistance Updates"},{"key":"380_CR17","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/ijc.30475","volume":"140","author":"H Nagase","year":"2017","unstructured":"Nagase H, Takeoka T, Urakawa S, Morimoto-Okazawa A, Kawashima A, Iwahori K, et al. ICOS+ Foxp3+ TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori. Int J Cancer. 2017;140:686\u201395.","journal-title":"Int J Cancer"},{"key":"380_CR18","first-page":"2505","volume":"31","author":"T Morisaki","year":"2011","unstructured":"Morisaki T, Onishi H, Koya N, Kiyota A, Tanaka H, Umebayashi M, et al. Combinatorial cytotoxicity of gemcitabine and cytokine-activated killer cells in hepatocellular carcinoma via the NKG2D-MICA\/B system. Anticancer Res. 2011;31:2505\u201310.","journal-title":"Anticancer Res"},{"key":"380_CR19","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0140-6736(09)60404-9","volume":"373","author":"ML Disis","year":"2009","unstructured":"Disis ML, Bernhard H, Jaffee EM. Use of tumour-responsive T cells as cancer treatment. Lancet. 2009;373:673\u201383.","journal-title":"Lancet"},{"key":"380_CR20","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1038\/onc.2008.272","volume":"27","author":"N Nausch","year":"2008","unstructured":"Nausch N, Cerwenka A. NKG2D ligands in tumor immunity. Oncogene. 2008;27:5944\u201358.","journal-title":"Oncogene"},{"key":"380_CR21","first-page":"3995","volume":"31","author":"H Onishi","year":"2011","unstructured":"Onishi H, Morisaki T, Baba E, Nakamura M, Inaba S, Kuroki H, et al. Long-term vaccine therapy with autologous whole tumor cell-pulsed dendritic cells for a patient with recurrent rectal carcinoma. Anticancer Res. 2011;31:3995\u20134005.","journal-title":"Anticancer Res"},{"key":"380_CR22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10120-006-0406-3","volume":"10","author":"S Nakagawa","year":"2007","unstructured":"Nakagawa S, Nashimoto A, Yabusaki H. Role of staging laparoscopy with peritoneal lavage cytology in the treatment of locally advanced gastric cancer. Gastric Cancer. 2007;10:29\u201334.","journal-title":"Gastric Cancer"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-017-0380-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40792-017-0380-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-017-0380-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T18:06:22Z","timestamp":1508781982000},"score":1,"resource":{"primary":{"URL":"http:\/\/surgicalcasereports.springeropen.com\/articles\/10.1186\/s40792-017-0380-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,23]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["380"],"URL":"https:\/\/doi.org\/10.1186\/s40792-017-0380-5","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,23]]},"article-number":"112"}}